Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Precision Biosciences Inc Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.15 - $3.34 $40,838 - $118,610	-35,512 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$2.96 - $7.76 $11,866 - $31,109	4,009 Added 12.73%	35,512 $109,000
Q4 2021 Feb 07, 2022	SELL	$7.4 - $11.66 $8,347 - $13,152	-1,128 Reduced 3.46%	31,503 $244,000
Q3 2021 Nov 04, 2021	SELL	$9.18 - $14.15 $3,653 - $5,631	-398 Reduced 1.21%	32,631 $377,000
Q2 2021 Aug 06, 2021	SELL	$8.07 - $12.52 $36,516 - $56,653	-4,525 Reduced 12.05%	33,029 $414,000
Q1 2021 May 06, 2021	BUY	$8.57 - $15.79 $102,788 - $189,385	11,994 Added 46.92%	37,554 $389,000
Q4 2020 Feb 09, 2021	BUY	$5.98 - $12.47 $152,848 - $318,733	25,560 New	25,560 $213,000

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

Oup Management Co., LLC

1.12M
Shares

$5.62 Million
0.86% of portfolio
Chi Advisors LLC New York, NY

607K
Shares

$3.03 Million
0.1% of portfolio
Jacob Asset Management Of New York LLC Hermosa Beach, CA

390K
Shares

$1.95 Million
0.19% of portfolio
Tekla Capital Management LLC

225K
Shares

$1.12 Million
0.0% of portfolio
Vericrest Private Wealth Newtown, PA

155K
Shares

$773,470
0.3% of portfolio

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account